Platelet-activating factor (PAF) receptor binding activity of the roots of Enicosanthellum pulchrum

References

• Braquet P, Spinnewyn B, Braquet M, Bourgain RH, Taylor JE, Etienne A, Drieu K (1985): BN 52021 and related compounds: A new series of highly specific PAF-acether receptor antagonist isolated from Ginkgo biloba. Blood Vess,16, 559–572.
   Google Scholar
• Burkill IH.(1966). A Dictionary of Economic Products of the Malay Peninsular. Kuala Lumpur, Malaysia: Ministry of Agriculture & Cooperatives.
   Google Scholar
• Camussi G, Tetta C, Bussolino F, Baglioni C. (1988). Synthesis and release of platelet-activating factor is inhibited by plasma alpha 1-proteinase inhibitor or alpha 1-antichymotrypsin and is stimulated by proteinases. J Exp Med, 168, 1293–1306.
   PubMed Web of Science ®Google Scholar
• Cave A, Cassels BK, Leboeuf M. (1987). Kinabaline and the aporphinoid biogenesis of azaanthracene and azafluorene alkaloid. Phytochemistry, 26, 537–541.
   Google Scholar
• David MJ. (1989). Revision of Disepalum (Annonaceae). Brittonia, 41, 359–378.
   Google Scholar
• Feuerstein G, Rabinovici R, Leor J, Winkler JD, Vonhof S. (1997). Platelet-activating factor and cardiac diseases: therapeutic potential for PAF inhibitors. J Lipid Mediat Cell Signal, 15, 255–284.
   PubMedGoogle Scholar
• Guinaudeau H, Leboeuf M, Cave A. (1983). Aporhinoid alkaloids III. J Nat Prod, 46, 761–835.
   Web of Science ®Google Scholar
• Imaizumi TA, Stafforini DM, Yamada Y, McIntyre TM, Prescott SM, Zimmerman GA. (1995). Platelet-activating factor: A mediator for clinicians. J Intern Med, 238, 5–20.
   PubMedGoogle Scholar
• Jalil J, Jantan I, Shaari K, Abdul Rafi IA. (2004). Bioassay-guided isolation of a potent platelet-activating factor antagonist alkenyiresorcinol from Ardisia elliptica. Pharm Biol, 42, 457–461.
   Web of Science ®Google Scholar
• Jantan I, Rafi IA, Jalil J. (2001a). Inhibition of platelet-activating factor receptor binding by aporphine and phenanthrenoid alkaloids from Aromadendron elegans. Planta Med, 67, 466–467.
   PubMedGoogle Scholar
• Jantan I, Jalil J, Abdul Warif NM. (2001b). Platelet-activating factor (PAF) antagonistic activities of compounds isolated from Guttiferae species. Pharm Biol, 39, 243–246.
   Web of Science ®Google Scholar
• Kuijpers TW, Hakkert BC, Hoogerwerf M, Leeuwenberg JF, Roos D. (1991). Role of endothelial leukocyte adhesion molecule-1 and platelet-activating factor in neutrophil adherence to IL-1-prestimulated endothelial cells. Endothelial leukocyte adhesion molecule-1-mediated CD18 activation. J Immunol, 147, 1369–1376.
   PubMed Web of Science ®Google Scholar
• Lavault M, Guinaudeau H, Bruneton J, Sevenet T, Hadi HA. (1990). (-)-Thaipetaline, a tetrahydroprotoberberine from a Malayan Annonaceae. Phytochemistry, 29, 3845–3847.
   Web of Science ®Google Scholar
• Lenz GR, Koszyk FJ. (1984). A biomimetic synthesis of the novel 6, 7-oxazine ring-fused dehydroaporphine alkaloid duguenaine. J Chem Soc Perkin Trans, 1, 1273–1277.
   Google Scholar
• O’Flaherty JT, Wykle RL, Miller CH, Lewis JC, Waite M, Bass DA, McCall CE, DeChatelet LR. (1981). 1-O-Alkyl-sn-glyceryl-3-phosphorylcholines: A novel class of neutrophil stimulants. Am J Pathol, 103, 70–78.
   PubMed Web of Science ®Google Scholar
• Okamoto M, Yoshida K, Nishikawa M, Ando T, Iwami M, Kohsaka M, Aoki H. (1986a). FR-900452, a specific antagonist of platelet activating factor (PAF) produced by Streptomyces phaeofaciens. I. Taxonomy, fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot, 39, 198–204.
   PubMedGoogle Scholar
• Okamoto M, Yoshida K, Nishikawa M, Kohsaka M, Aoki H. (1986b). Platelet activating factor (PAF) involvement in endotoxin-induced thrombocytopenia in rabbits: Studies with FR-900452, a specific inhibitor of PAF. Thromb Res, 42, 661–671.
   PubMedGoogle Scholar
• Okamoto M, Yoshida K, Uchida I, Nishikawa M, Kohsaka M, Aoki H. (1986c). Studies of platelet activating factor (PAF) antagonists from microbial products. I. Bisdethiobis(methylthio)gliotoxin and its derivatives. Chem Pharm Bull, 34, 340–344.
   PubMed Web of Science ®Google Scholar
• Okamoto M, Yoshida K, Uchida I, Kohsaka M, Aoki H. (1986). Studies of platelet activating factor (PAF) antagonists from microbial products. II. Pharmacological studies of FR-49175 in animal models. Chem Pharm Bull, 34, 345–348.
   PubMedGoogle Scholar
• Okamoto M, Yoshida K, Nishikawa M, Hayashi K, Uchida I, Kohsaka M, Aoki H. (1986e). Studies of platelet activating factor (PAF) antagonists from microbial products. III. Pharmacological studies of FR-900452 in animal models. Chem Pharm Bull, 34, 3005–3010.
   PubMedGoogle Scholar
• Shaw JO, Pinckard RN, Ferrigni KS, McManus LM, Hanahan DJ. (1981). Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor). J Immunol, 127, 1250–1255.
   PubMed Web of Science ®Google Scholar
• Shen TY, Hwang SB, Chang MN, Doebber TW, Lam MH, Wu MS, Wang X, Han GQ, Li RZ. (1985). Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects. Proc Natl Acad Sci USA, 82, 672–676.
   PubMedGoogle Scholar
• Verghese MW, Charles L, Jakoi L, Dillon SB, Snyderman R. (1987). Role of a guanine nucleotide regulatory protein in the activation of phospholipase C by different chemoattractants. J Immunol, 138, 4374–4380.
   PubMed Web of Science ®Google Scholar
• Waterman PG, Muhammad I. (1985). Sesquiterpenes and alkaloids from Cleistopholis patens. Phytochemistry, 24, 523–527.
   Web of Science ®Google Scholar
• Wijeratne EMK, Hatanaka Y, Kikuchi T, Tezuka Y, Gunatilaka AAL. (1996). A dioxo-aporphine and other alkaloids of two annonaceous plants of Sri Lanka. Phytochemistry, 42, 1703–1706.
   Web of Science ®Google Scholar
• Yang HO, Suh DY, Han BH. (1995). Isolation and characterization of platelet-activating factor receptor binding antagonists from Biota orientalis. Planta Med, 61, 37–40.
   PubMed Web of Science ®Google Scholar
• Zimmerman GA, Prescott SM, McIntyre TM. (1992). Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today, 13, 93–100.
   PubMedGoogle Scholar
• Zimmerman GA, McIntyre TM, Prescott SM, Stafforini DM. (2002). The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med, 30, S294–S301.
   PubMed Web of Science ®Google Scholar